SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending following a rally, fueled by reports of corporate accumulation, discussions of a potential "COEP merger" within its mining ecosystem, and speculative short squeeze plays. While many in the community anticipate further gains amidst a broader "meme season" and potential integration with Elon Musk's X platform, others remain cautious, citing its historical volatility and the risk of a "pump and dump."

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound (COMP) is trending amidst intense community debate, with many bulls citing its near-maxed token supply, anticipated V4 upgrades, and rumored fintech partnerships as catalysts for a significant price movement, while others express frustration over its historical underperformance and perceived "pump and dump" cycles.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

PEPE is trending amidst a perceived new "meme coin season" and broader altcoin momentum, sparking intense debate within the community between those anticipating significant upward movement and skeptics predicting an imminent downturn.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is trending as its recently FDA-approved drug, Yartemlea, has begun commercial sales as the first and only treatment for severe TA-TMA, driving community anticipation of significant revenue growth and potential acquisition interest from partners like Novo Nordisk. However, market conversations reflect frustration over artificial price suppression, linked to options dynamics and skepticism about initial market penetration, despite strong underlying fundamentals.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending with a notable price surge and reports of short liquidations, fueling community discussions around its potential "decoupling" from other major cryptocurrencies. Investors are actively debating the impact of anticipated regulatory clarity and growing institutional adoption, particularly given recent reports of major financial institutions holding XRP-related exchange-traded funds and its perceived utility as a bridge asset.

BlackRock Institutional Trust Company N.A. - iShares MSCI India ETF

iShares MSCI India ETF

INDA is a hot topic as the market closely tracks high-stakes US-India trade negotiations, with community sentiment focusing on a potential deal to resolve tariff disputes and solidify India's emerging role in a rebalancing global economy.

SSgA Active Trust - State Street Technology Select Sector SPDR ETF

Technology Select Sector SPDR Fund

XLK is trending amid community discussion about a significant sector rotation away from mega-cap technology towards energy and defensive plays, exacerbated by increasing concerns over tech valuations and prominent bearish technical signals despite some strong individual earnings reports.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending ahead of its highly anticipated earnings report, with the community eager for insights into its revenue growth and path to profitability. This is amplified by heavy discussion around a potential short squeeze, driven by significant institutional accumulation and the company's patented conversational AI technology being adopted across numerous enterprise partnerships.

Bank of Montreal engages in the provision of banking and financial services to individuals and institutions. It operates through the following segments: Canadian Personal and Commercial Banking (Canadian P&C), United States Personal and Commercial Banking (U.S. P&C), BMO Wealth Management, BMO Capital Markets, and Corporate Services. The company was founded by Robert Armour, John C. Bush, Austin Cuvillier, George Garden, Horatio Gates, James Leslie, George Moffatt, John Richardson and Thomas A. Turner on June 23, 1817 and is headquartered in Toronto, Canada.

Bank of Montreal - MicroSectors Gold Miners 3X Leveraged ETN

GDXU, a 3x leveraged gold miners ETN, is seeing intense trading activity as gold prices surge to new highs amid geopolitical tensions and inflation concerns, triggering massive volatility. The community is heavily engaged in aggressive swing trading and dip buying, despite sharp intraday corrections, driven by a conviction in gold's long-term bullish tailwinds.

Linea is the Layer 2 built from first principles to strengthen Ethereum and the entire ETH economy. Every aspect of its design—from its productive ETH burn mechanics, and capital efficient native yield, to its underlying Ethereum-equivalent zk tech—amplifies the value and utility of Ethereum Mainnet. All of this is backed by the largest ecosystem fund in the space, managed by the most trusted Ethereum builders. With institutional-grade infrastructure, and deep integration across DeFi, Linea is the best chain for ETH capital, where every transaction and every block strengthens Ethereum. Linea is where Ethereum wins.

Linea

Linea Crypto is trending due to widespread community discussion surrounding its reported involvement in the SWIFT banking network's digital asset pilot. This potential institutional validation for the Ethereum Layer-2 solution is driving conversation about its future in cross-border payments, even as some express concern over token unlocks and price volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Given Consensus Recommendation of "Hold" by Brokerages

Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) have been given a consensus rating of "Hold" by the five analysts that are presently covering the firm, Marketbeat.com reports...

Illumina (ILMN) Tops Q4 Earnings and Revenue Estimates

Illumina (ILMN) delivered earnings and revenue surprises of +7.42% and +0.35%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Techne (TECH) Beats Q2 Earnings and Revenue Estimates

Techne (TECH) delivered earnings and revenue surprises of +8.24% and +1.32%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Goldman's Small-Cap Biotech Universe: The 2026 Catalyst Playbook For Investors

Goldman's Small-Cap Biotech Universe: The 2026 Catalyst Playbook For Investors There are just nine days left in the year, and this year has flown by. We've delivered readers a steady stream of 2026...

5AM Venture Management LLC Has $28.95 Million Stake in Entrada Therapeutics, Inc. $TRDA

5AM Venture Management LLC trimmed its stake in Entrada Therapeutics, Inc. (NASDAQ:TRDA - Free Report) by 2.3% in the 2nd quarter, according to the company in its most recent 13F filing with the...

Kory James Wentworth Sells 8,910 Shares of Entrada Therapeutics (NASDAQ:TRDA) Stock

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) CFO Kory James Wentworth sold 8,910 shares of Entrada Therapeutics stock in a transaction dated Friday, November 21st. The stock was sold at...

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Given Average Recommendation of "Moderate Buy" by Analysts

Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) have earned an average recommendation of "Moderate Buy" from the five research firms that are currently covering the firm...

Ventures L.P. 5Am Sells 200,000 Shares of Entrada Therapeutics (NASDAQ:TRDA) Stock

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) major shareholder Ventures L.P. 5Am sold 200,000 shares of Entrada Therapeutics stock in a transaction that occurred on Friday, November...

Insider Selling: Entrada Therapeutics (NASDAQ:TRDA) Director Sells 200,000 Shares of Stock

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) Director Kush Parmar sold 200,000 shares of the company's stock in a transaction on Friday, November 14th. The stock was sold at an average...

Insider Buying: Entrada Therapeutics (NASDAQ:TRDA) Major Shareholder Buys 30,874 Shares of Stock

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) major shareholder Bros. Advisors Lp Baker acquired 30,874 shares of the firm's stock in a transaction dated Monday, November 10th. The stock...

Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company’s Endosomal Escape Vehicle (EEV) therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Through this proprietary, versatile and modular approach, Entrada is advancing a robust development portfolio of RNA- and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. The company’s oligonucleotide programs are in development for the potential treatment of people living with Duchenne who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1. Entrada Therapeutics was founded by Dehua Pei in 2016 and is headquartered in Boston, MA.

Entrada Therapeutics Inc

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

TRDA
Entrada Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest TRDA News

TRDAEntrada Therapeutics Inc